Drug General Information
Drug ID	D0E9TP
Former ID	DAP000866
Drug Name	Sulodexide
Indication	Central or sensorineural tinnitus [ICD9: 388.3; ICD10:H93.1]		Approved	[536297]
Therapeutic Class	Antithrombotic Agents
Structure		Download 2D MOL 3D MOL
CAS Number	CAS 57821-29-1
SuperDrug ATC ID	B01AB11
Target and Pathway
Target(s)	Antithrombin-III	Target Info	Activator	[537594], [538076]
KEGG Pathway	Complement and coagulation cascades
PANTHER Pathway	Blood coagulation
Pathway Interaction Database	Glypican 1 network
Reactome	Intrinsic Pathway of Fibrin Clot Formation
	Common Pathway of Fibrin Clot Formation
WikiPathways	Complement and Coagulation Cascades
	Formation of Fibrin Clot (Clotting Cascade)
References
Ref 536297	Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006 Nov;11(4):709-24.
Ref 537594	Management of tinnitus: oral treatment with melatonin and sulodexide. J Biol Regul Homeost Agents. 2009 Apr-Jun;23(2):103-10.
Ref 538076	Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide. Med Res Rev. 1998 Jan;18(1):1-20.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.